Publications by authors named "Kuo-Ging Lin"

Claim this Profile
I
Innovative cyclic peptide disrupts IL-17RB-MLK4 interaction for targeted pancreatic cancer therapy.
Chun-Mei Hu, Sui-Chih Tien, Yung-Chen Lo, Ching-Hsuan Huang, Yi-Ling Ko, Kuo-Ging Lin

Biomed Pharmacother· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimeric TAT peptides are effective in vitro inhibitors of Staphylococcus saprophyticus.
Justin Brian V Chiongson, Edna M Sabido, Kuo-Ging Lin, Glenn V Alea, Doralyn S Dalisay

Chem Biol Drug Des· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new N-acetylgalactosamine containing peptide as a targeting vehicle for mammalian hepatocytes via asialoglycoprotein receptor endocytosis.
Ying-Ta Wu, Weir-Torn Jiaang, Kuo-Ging Lin, Chun-Ming Huang, Chin-Hsien Chang, Ying-Ling Sun, Shwu-Bin Lin

Curr Drug Deliv· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis